Opus Genetics, Inc.

IRD Stock Healthcare Biotechnology
$3.83
+0.21 (+5.80%)
Price as of Sep 01, 2026 market close

Performance

1 Month
+5.2%
3 Months
-4.0%
YTD
+90.5%
1 Year
+213.9%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
74.2%
Largest decline max drawdown, since Aug 2025
-49.2%
Risk-adjusted return Sharpe ratio, 1-year
1.91

Own IRD?

See how IRD contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.